Integra LifeSciences Corporation (IART) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Integra LifeSciences Cor... (IART)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

21.91

-0.38 (-1.70%)

At close: Jan 14, 2025, 3:59 PM

undefined% (undefined)

Bid	21.5
Market Cap	1.69B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.09
PE Ratio (ttm)	-243.44
Forward PE	n/a
Analyst	Sell

Ask	22
Volume	238,944
Avg. Volume (20D)	760,490
Open	22.33
Previous Close	22.29
Day's Range	21.27 - 22.56
52-Week Range	16.81 - 45.42
Beta	undefined

About IART

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracrani...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Aug 16, 1995

Employees 3,946

Stock Exchange NASDAQ

Ticker Symbol IART

Website https://www.integralife.com

Analyst Forecast

According to 7 analyst ratings, the average rating for IART stock is "Sell." The 12-month stock price forecast is $22, which is an increase of 0.41% from the latest price.

Buy 14.29%

Hold 42.86%

Sell 42.86%

Stock Forecasts

Next Earnings Release

Integra LifeSciences Corporation is scheduled to release its earnings on Feb 26, 2025, before market opens.
Analysts project revenue of $445.15M, reflecting a 12.12% YoY growth and earnings per share of 0.85, making a -4.49% decrease YoY.

Why Price Moved

2 months ago · Source

+25.1%

Integra LifeSciences shares are trading higher aft... Unlock content with Pro Subscription

5 months ago · Source

-1.53%

Integra Lifesciences shares are trading lower after Citigroup and BTIG both downgraded the stock from Neutral to Sell. The company recently lowered its FY24 guidance.

News

1 week ago · zacks.com

IART or PEN: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Integra LifeSciences (IART) or Penumbra (PEN). But which of these two stocks presents investors with the ...

1 week ago · zacks.com

Invest in These 4 Value Stocks for Promising 2025 Returns

Value investing is essentially about selecting stocks that are cheap but fundamentally sound. TSN, GM, MGNI & IART boast a low P/CF ratio.

1 week ago · zacks.com

Is Integra LifeSciences (IART) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

2 weeks ago · zacks.com

Here's Why You Should Hold IART Stock in Your Portfolio Now

Integra's growth within its Tissue Technologies business segment bolsters investors' confidence in the stock.

1 month ago · zacks.com

Reasons to Retain IART Stock in Your Portfolio for Now

Integra's strong growth in the CSS business segment bolsters investors' confidence in the stock. Meanwhile, the weak liquidity position adds to the worry.

2 months ago · zacks.com

IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant

According to a health economic evaluation, Integra's DuraSeal Dural Sealant is revealed to reduce healthcare costs.

2 months ago · zacks.com

Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure

IART is optimistic about the fact that the shipping holds have largely been resolved within the third quarter.

2 months ago · seekingalpha.com

Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript

Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q3 2024 Earnings Call Transcript November 4, 2024 8:30 AM ET Company Participants Chris Ward - IR Stuart Essig - Executive Chairman Jan De Witt...

2 months ago · zacks.com

Integra (IART) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compa...

2 months ago · zacks.com

Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates

Integra LifeSciences (IART) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.76 per share a year ago.